Skip to main content

Johnathan Lancaster

Johnathan Lancaster has joined Myriad Genetics as the vice president of Medical Affairs for Oncology, effective Feb. 9. He will provide medical and scientific leadership across the company's portfolio of molecular and companion diagnostic products and services for oncology. Lancaster will report to Lloyd Sanders, GM for the oncology business unit at Myriad Genetic Laboratories. 

Lancaster has spent the past 12 years at Moffitt Cancer Center, where he's held several posts, including president of Moffitt Medical Group, deputy physician-in-chief and director of the Center for Women's Oncology, and chair of the department of women's oncology. Prior to Moffitt, he was medical director of the Gynecology Dysplasia Clinic at Duke University Medical Center.

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.